{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:35Z","timestamp":1747181195915,"version":"3.40.5"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Acquired hemophilia A (AHA) is a rare autoimmune disease caused by an antibody that inhibits coagulation factor VIII activity. More than half of patients with AHA cannot identify underlying disorders. The remaining patients are associated with malignancies, autoimmune diseases, skin diseases, infections, and medications. Here, we present a case of 56-year-old Korean man with underlying hypertension, dyslipidemia, and diabetes mellitus who developed AHA following the second dose of BNT162b2 COVID-19 vaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>He presented with a large 20\u2005\u00d7\u200530 cm-sized hematoma along the psoas muscle and intracranial hemorrhage, necessitating intensive care with mechanical ventilation and continuous renal replacement therapy. Laboratory testing demonstrated that activated partial thromboplastin time and prothrombin times were 74.7 seconds (normal range 29\u201343 seconds) and 17.2 seconds (normal range 12.5\u201314.7 seconds), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Laboratory tests confirmed AHA with undetectable factor VIII activity (&lt;1.5%) and a positive factor VIII antibody with a titer of 8.49 Bethesda units\/mL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Recombinant factor VIIa (NovoSeven<jats:sup>\u00ae<\/jats:sup>) was administered every 2 hours to control the bleeding, alongside immunosuppression with methylprednisolone 1\u2009mg\/kg daily and cyclophosphamide 2\u2009mg\/kg daily to eliminate the autoantibody.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Despite the treatments, the patient developed sepsis and succumbed 14 weeks after admission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This rare case underscores the importance of monitoring for AHA following COVID-19 vaccination. Although the benefits outweigh the risks of vaccination, AHA should be considered in the differential diagnosis of unusual bleeding following the vaccinations. Early diagnosis and management before severe bleeding are critical for successfully controlling life-threatening bleeding.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039166","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:20:09Z","timestamp":1722619209000},"page":"e39166","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Severe acquired hemophilia A associated with COVID-19 vaccination: A case report and literature review"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2603-2305","authenticated-orcid":false,"given":"Hong Jun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Hematology and Medical Oncology, Kyung Hee University, College of Medicine, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye Ji","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Kyung Hee University, College of Medicine, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Kyung Hee University, College of Medicine, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Jung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Kyung Hee University, College of Medicine, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Hoon","family":"Maeng","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Kyung Hee University, College of Medicine, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Kyung","family":"Baek","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Kyung Hee University, College of Medicine, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Joon","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Kyung Hee University, College of Medicine, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation.","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).","volume":"10","author":"Knoebl","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2516.2011.02493.x","article-title":"A case of acquired haemophilia following H1N1 vaccination.","volume":"5","author":"Pirrotta","year":"2011","journal-title":"Haemophilia"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00228-010-0852-z","article-title":"Acquired factor VIII haemophilia following influenza vaccination.","volume":"66","author":"Moulis","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1111\/hae.14370","article-title":"Clinical characteristics and prognostic factors of acquired haemophilia A in Korea.","volume":"27","author":"Hyun","year":"2021","journal-title":"Haemophilia"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/JBM.S284804","article-title":"Acquired hemophilia A: current guidance and experience from clinical practice.","volume":"13","author":"Pishko","year":"2022","journal-title":"J Blood Med"},{"key":"R7-20250503","first-page":"15","article-title":"Investigating a signal of acquired hemophilia associated with COVID-19 vaccination: a systematic case review.","volume":"49","author":"Franchini","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"R8-20250503","first-page":"245","article-title":"Acquired haemophilia A: Italian consensus recommendations on diagnosis, general management and treatment of bleeding.","volume":"20","author":"Coppola","year":"2022","journal-title":"Blood Transfus"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1471-0528.2012.03469.x","article-title":"Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.","volume":"119","author":"Tengborn","year":"2012","journal-title":"BJOG"},{"key":"R10-20250503","first-page":"e21909","article-title":"Acquired hemophilia A post-COVID-19 vaccination: a case report and review.","volume":"14","author":"Al Hennawi","year":"2022","journal-title":"Cureus"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1177\/10781552221075545","article-title":"Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab.","volume":"28","author":"Murali","year":"2022","journal-title":"J Oncol Pharm Pract"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"e246922","DOI":"10.1136\/bcr-2021-246922","article-title":"Case of acquired Haemophilia A in Southeast Asia following COVID-19 vaccine.","volume":"15","author":"Ai Vuen","year":"2022","journal-title":"BMJ Case Rep"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1055\/a-1579-5396","article-title":"Autoimmunity after coronavirus disease 2019 (COVID-19) vaccine: a case of acquired hemophilia A.","volume":"121","author":"Farley","year":"2021","journal-title":"Thromb Haemost"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.thromres.2022.01.017","article-title":"Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine.","volume":"211","author":"Leone","year":"2022","journal-title":"Thromb Res"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"868133","DOI":"10.3389\/fimmu.2022.868133","article-title":"Case report: acquired haemophilia A following mRNA-1273 booster vaccination against SARS-CoV-2 with concurrent diagnosis of pleomorphic dermal sarcoma.","volume":"13","author":"Pl\u00fc\u00df","year":"2022","journal-title":"Front Immunol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/hae.14442","article-title":"A case of acquired haemophilia A in a 70-year-old post COVID-19 vaccine.","volume":"28","author":"Lemoine","year":"2022","journal-title":"Haemophilia"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.jfma.2022.02.017","article-title":"A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination.","volume":"121","author":"Fu","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/jth.15421","article-title":"The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination.","volume":"19","author":"Cittone","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jth.15291","article-title":"A case report of acquired hemophilia following COVID-19 vaccine.","volume":"19","author":"Radwi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/jmc3827","article-title":"Acquired hemophilia A developed post COVID-19 vaccine: an extremely rare complication.","volume":"13","author":"Soliman","year":"2022","journal-title":"J Med Cases"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2011.08890.x","article-title":"Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?","volume":"156","author":"Mahendra","year":"2012","journal-title":"Br J Haematol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/jha2.604","article-title":"Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: a systematic review.","volume":"4","author":"Amisha","year":"2023","journal-title":"EJHaem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:11:39Z","timestamp":1746317499000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":22,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039166","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}